Use of Program Sample Clauses

The "Use of Program" clause defines the terms under which a user is permitted to access and utilize a specific software program. Typically, it outlines the scope of authorized activities, such as installation, execution, and any restrictions on copying, modifying, or distributing the program. For example, it may specify that the program can only be used for internal business purposes and not for commercial resale. This clause serves to protect the intellectual property rights of the software provider and ensures that users understand the boundaries of lawful use, thereby reducing the risk of misuse or unauthorized distribution.
Use of Program. 5.3.1. The way You use the Program is solely dependant on You. You shall not claim Forex4you concerning this matter since the outcoming results are generated directly by You in person or Your omission during their use. WE STRICTLY RECOMMEND PRIOR THE USE OF THE PROGRAM PLEASE TEST IT ACCORDINGLY AND GET ACQUAINTED WITH THE OUTCOMING RESULTS TO BE SURE THEY MATCH YOUR INTERESTS AND EXPECTATIONS. 5.3.2. REMEMBER! You are going to run a Program that has partial access to your mobile device contents. You should only run such Program if you get it from a trusted and officially recognized by Forex4you source; you should not run such a Program if you are in doubt about the potential consequences of using it the origins of the Program are not clear to you.
View SourceView Similar (2)
Use of Program. Identification, Resellers may use the VentureTech Network™ Trademark, service ▇▇▇▇ and related logos (“ VentureTech Network™ Trademarks”) to identify the Services provided through the VentureTech Network™ Program to its end user customers. Reseller acknowledges that t he VentureTech Network™ Trademark is the exclusive property of ▇▇▇▇▇▇ Micro and that it may not be duplicated or distributed to be used by anyone, unle ▇▇ ▇▇▇▇▇▇ Micro first gives its permis- sion, and that Reseller’s only rights to the VentureTech Network™ Trademarks are as set forth in this Agreement and the Channel Program Guide. Any unauthorized use of the VentureTech Network™ Trademarks will constitute on the rights of ▇▇▇▇▇▇ Micro for which Reseller may be liable for damag es or subject to equitable relief to
View Source
Use of Program. Identification, Resellers may use the VentureTech Network™ Trademark, service ▇▇▇▇ and related logos (“VentureTech Network™ Trademarks”) to identify the Services provided through the VentureTech Network™ Program to its end user customers. Reseller acknowledges that the VentureTech Network™ Trademark is the exclusive property of ▇▇▇▇▇▇ Micro and that it may not be duplicated or distributed to be used by anyone, unless ▇▇▇▇▇▇ Micro first gives its permission, and that Reseller’s only rights to the VentureTech Network™ Trademarks are as set forth in this Agreement and the Channel Program Guide. Any unauthorized use of the VentureTech Network™ Trademarks will constitute on the rights of ▇▇▇▇▇▇ Micro for which Reseller may be liable for damages or subject to equitable relief to the bene- fit of ▇▇▇▇▇▇ Micro. Reseller shall not use the VentureTech Network™ Trademarks as part of its corporate, legal or DBA name unless ▇▇▇▇▇▇ Micro first gives its permis- sion. Reseller understands that his Agreement does not give reseller any rights to use any other trademarks as may be owned by ▇▇▇▇▇▇ Micro, other than the right to use the VentureTech Network™ Trademarks.
View Source
Use of Program. Income 1. In accordance with 2 CFR 200.307 and 2 CFR 1500.7 the CAR is authorized to add program income to the funds awarded by the EPA and use the program income under the same terms and conditions of this agreement. Program income for the RLF shall be defined as the gross income received by the recipient, directly generated by the cooperative agreement award or earned during the period of the award. Program income shall include principal repayments, interest earned on outstanding loan principal, interest earned on accounts holding RLF program income not needed for immediate lending, all loan fees and loan-related charges received from borrowers and other income generated from RLF operations including proceeds from the sale, collection, or liquidations of assets acquired through defaults of loans. 2. In accordance with Section 104(d)(3)(D), when a CAR transitions to a 104(k) cooperative agreement, any program income (e.g. fees, interest or principal repayments) generated prior to transition will be added to the 104(k) agreement and must be used in a manner consistent with Section 104(k)(3) and with the terms and conditions, contained herein. 3. The CAR may use program income from fees, interest payments from loans, and other forms of eligible program income to meet its cost-share. The CAR shall not use repayments of principal of loans to meet the CAR’s cost-share requirement. Repayments of principal must be returned to the CAR’s Brownfields cleanup revolving fund. 4. The CAR that elects to use program income to cover all or part of an RLF's programmatic costs shall maintain adequate accounting records and source documentation to substantiate the amount and percent of program income expended for eligible RLF programmatic costs, and comply with applicable OMB cost principles when charging costs against program income. For any cost determined by the EPA to have been an ineligible use of program income, the recipient shall reimburse the RLF or the EPA. EPA will notify the recipient of the time period allowed for reimbursement. 5. Loans or subawards made with a combination of program income and direct funding from EPA are subject to the same terms and conditions as those applicable to this agreement. Loans and subawards made with direct funding from EPA in combination with non Federal sources of funds are also subject to the same terms and conditions of this agreement. 6. The CAR must obtain EPA approval of the substantive terms of loans and subawards made ent...
View Source
Use of Program. Benefited Antibodies After Expiration of the Evaluation Term. After the expiration of the Evaluation Term with respect to a Research Program, Alector and its Licensees will not research, develop, manufacture or commercialize (i) Program-Benefited Antibodies within such Research Program other than Optioned Antibodies or (ii) Non-Optioned Antibodies from such Research Program.
View Source
Use of Program. 5.3.1. The way You use the Program is solely dependant on You. You shall not claim SinoxFX concerning this matter since the out coming results are generated directly by You in person or Your omission during their use. WE STRICTLY RECOMMEND PRIOR THE USE OF THE PROGRAM PLEASE TEST IT ACCORDINGLY AND GET ACQUAINTED WITH THE OUTCOMING RESULTS TO BE SURE THEY MATCH YOUR INTERESTS AND EXPECTATIONS. 5.3.2. REMEMBER! You are going to run a Program that has partial access to your mobile device contents. You should only run such Program if you get it from a trusted and officially recognized by SinoxFX source; you should not run such a Program if you are in doubt about the potential consequences of using it the origins of the Program are not clear to you.
View Source
Use of Program. 2.4.1. A Program is considered to be in use when it resides in memory or is otherwise stored on a machine. A Program stored on a network server solely for the purpose of being distributed to other machines is not considered to be in use. 2.4.2. You are permitted to load the Software and use it on a computer, which is owned by you at your premises for purposes of your own business. 2.4.3. You are not permitted to sell, rent, lease, sub-licence, loan, copy, modify, adapt, merge, translate, reverse engineer, decompile, disassemble or create derivative works based on the whole or any part of the Software or its associated documentation.
View Source
Use of Program. Benefited Antibodies During the Evaluation Term. During the Evaluation Term with respect to a Research Program, Alector will not seek to or actually research, develop or commercialize any Program-Benefited Antibody, or product containing the foregoing, other than the activities permitted hereunder during the Research Term and the Evaluation Term for the purpose of performing its obligations under this Agreement and a Research Plan and determining whether or not to exercise the Option for a given Research Program.
View Source
Use of Program 
View Source

Related to Use of Program

  • Use of Project Issuer does hereby covenant and agree that it will not take any action during the term of this Agreement, other than pursuant to Article IX of this Agreement or Article IX of the Indenture, to interfere with Company's ownership of the Project or to prevent Company from having possession, custody, use and enjoyment of the Project.

  • Use of Products 3.28.1 In the performance of this Agreement, Consultant shall make maximum use of products containing recovered materials that are EPA-designated items unless the product cannot be acquired (i) competitively within a timeframe providing for compliance with the contract performance schedule; (ii) meeting contract performance requirements; or (iii) at a reasonable price. 3.28.2 Consultant shall abide by the list of EPA-designated items available on EPA’s Comprehensive Procurement Guidelines web site: ▇▇▇▇▇://▇▇▇.▇▇▇.▇▇▇/smm/comprehensive-procurement-guideline-cpg-program.

  • Use of websites (a) The Borrower may satisfy its obligation under this Agreement to deliver any information in relation to those Lenders (the “Website Lenders”) who accept this method of communication by posting this information onto an electronic website designated by the Borrower and the Agent (the “Designated Website”) if: (i) the Agent expressly agrees (after consultation with each of the Lenders) that it will accept communication of the information by this method; (ii) both the Borrower and the Agent are aware of the address of and any relevant password specifications for the Designated Website; and (iii) the information is in a format previously agreed between the Borrower and the Agent. If any Lender (a “Paper Form Lender”) does not agree to the delivery of information electronically then the Agent shall notify the Borrower accordingly and the Borrower shall supply the information to the Agent (in sufficient copies for each Paper Form Lender) in paper form. In any event the Borrower shall supply the Agent with at least one copy in paper form of any information required to be provided by it. (b) The Agent shall supply each Website Lender with the address of and any relevant password specifications for the Designated Website following designation of that website by the Borrower and the Agent. (c) The Borrower shall promptly upon becoming aware of its occurrence notify the Agent if: (i) the Designated Website cannot be accessed due to technical failure; (ii) the password specifications for the Designated Website change; (iii) any new information which is required to be provided under this Agreement is posted onto the Designated Website; (iv) any existing information which has been provided under this Agreement and posted onto the Designated Website is amended; or (v) the Borrower becomes aware that the Designated Website or any information posted onto the Designated Website is or has been infected by any electronic virus or similar software. If the Borrower notifies the Agent under paragraph (c)(i) or paragraph (c)(v) above, all information to be provided by the Borrower under this Agreement after the date of that notice shall be supplied in paper form unless and until the Agent and each Website Lender is satisfied that the circumstances giving rise to the notification are no longer continuing. (d) Any Website Lender may request, through the Agent, one paper copy of any information required to be provided under this Agreement which is posted onto the Designated Website. The Borrower shall comply with any such request within ten Business Days.

  • Use of PTO A nurse will be required to take his or her accrued PTO during the leave, except where required by law. a. Notwithstanding the foregoing, for absences greater than thirty (30) days, a nurse will be allowed to leave up to eighty (80) accrued hours remaining in his/her PTO bank. Such a nurse shall designate to the Medical Center, prior to the announcement of such absence, the date by which compensation for PTO is to be discontinued. b. The number of hours of PTO used per week during the leave may not be less than the number of hours that the nurse was regularly scheduled to work.

  • Use of Pronouns All pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the person or persons referred to may require.